These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20436047)

  • 21. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.
    Lu C; Gao Y; Zhou H; Tian H
    Coron Artery Dis; 2008 Dec; 19(8):565-73. PubMed ID: 19005291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up.
    Hadaegh F; Ehteshami-Afshar S; Hajebrahimi MA; Hajsheikholeslami F; Azizi F
    Int J Cardiol; 2015 Mar; 182():334-9. PubMed ID: 25585379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.
    Qiao Q; Tuomilehto J; Borch-Johnsen K
    Diabetologia; 2003 Mar; 46 Suppl 1():M17-21. PubMed ID: 12652354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus.
    Satoh H; Terada H; Uehara A; Katoh H; Matsunaga M; Yamazaki K; Matoh F; Hayashi H
    Heart; 2005 Jun; 91(6):731-6. PubMed ID: 15894763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
    Makino A; Nakamura T; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
    Atherosclerosis; 2010 Dec; 213(2):573-8. PubMed ID: 20934703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes.
    Scholte AJ; Schuijf JD; Kharagjitsingh AV; Jukema JW; Pundziute G; van der Wall EE; Bax JJ
    Heart; 2008 Mar; 94(3):290-5. PubMed ID: 17646190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of visceral fat distribution to angiographically assessed coronary artery disease: results in subjects with or without diabetes or impaired glucose tolerance.
    Morricone L; Donati C; Hassan T; Cioffi P; Caviezel F
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):275-83. PubMed ID: 12616807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina.
    Fu CP; Sheu WH; Lee WL; Lee WJ; Wang JS; Lin SY; Lee IT
    PLoS One; 2018; 13(8):e0202280. PubMed ID: 30110378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated post-challenge hyperglycaemia and risk of cardiovascular events: Tehran Lipid and Glucose Study.
    Barzin M; Hosseinpanah F; Malboosbaf R; Hajsheikholeslami F; Azizi F
    Diab Vasc Dis Res; 2013 Jul; 10(4):324-9. PubMed ID: 23291339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction.
    Schiele F; Descotes-Genon V; Seronde MF; Blonde MC; Legalery P; Meneveau N; Ecarnot F; Mercier M; Penfornis A; Thebault L; Boumal D; Bassand JP;
    Diabet Med; 2006 Dec; 23(12):1370-6. PubMed ID: 17116190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart.
    Anselmino M; Ohrvik J; Malmberg K; Standl E; Rydén L;
    Eur Heart J; 2008 Jan; 29(2):177-84. PubMed ID: 18156611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes, hyperglycaemia and mortality in disabled older women: The Women's Health and Ageing Study I.
    Blaum CS; Volpato S; Cappola AR; Chaves P; Xue QL; Guralnik JM; Fried LP
    Diabet Med; 2005 May; 22(5):543-50. PubMed ID: 15842507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of postprandial hyperglycaemia on coronary flow reserve in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Ikeda H; Uzui H; Morishita T; Fukuoka Y; Sato T; Ishida K; Kaseno K; Arakawa K; Amaya N; Tama N; Shiomi Y; Lee JD; Tada H
    Diab Vasc Dis Res; 2015 Nov; 12(6):405-10. PubMed ID: 26297527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-challenge hyperglycaemia is an independent risk factor for arterial stiffness in Japanese men.
    Ohshita K; Yamane K; Ishida K; Watanabe H; Okubo M; Kohno N
    Diabet Med; 2004 Jun; 21(6):636-9. PubMed ID: 15154954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.